Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients
- PMID: 30266609
- PMCID: PMC6394826
- DOI: 10.1016/j.jaapos.2018.07.347
Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients
Comment in
-
Reply.J AAPOS. 2018 Dec;22(6):484-485. doi: 10.1016/j.jaapos.2018.10.004. Epub 2018 Oct 28. J AAPOS. 2018. PMID: 30394341 No abstract available.
Comment on
-
Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients.J AAPOS. 2018 Jun;22(3):192-196. doi: 10.1016/j.jaapos.2018.01.017. Epub 2018 May 4. J AAPOS. 2018. PMID: 29733899
References
-
- Rice ML, Wong B, Horn PS, Yang MB. Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients. J AAPOS 2018;22:192–6. - PubMed
-
- Pillers DA, Fitzgerald KM, Duncan NM, et al. Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations. Hum Genet 1999;105:2–9. - PubMed
-
- Kurihara T, Kishi M, Saito N, Komoto M, Hidaka T, Kinoshita M. Electrical myotonia and cataract in X-linked muscular dystrophy (mdx) mouse. J Neurol Sci 1990;99:83–92. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical